A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ED
Long Form : Eales' disease
No. Year Title Co-occurring Abbreviation
2018 Role of Intravitreal Bevacizumab in Management of Eale's Disease. AFIO, IVB
2017 The 88-kDa Eales' protein in serum is a complex of haptoglobin, complement C3, and galectin-1 as identified by liquid chromatography coupled mass spectrometry. ---
2016 Localization of Human Copper Transporter 1 in the Eye and its Role in Eales Disease. CTR1
2016 Ultra-wide field angiography in the management of Eales disease. CNP, UWF
2014 Angiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales' Disease patients. MH, PDR
2013 Increased homocysteine, homocysteine-thiolactone, protein homocysteinylation and oxidative stress in the circulation of patients with Eales' disease. ARMD, CRVO, TBARS
2013 Tubercular retinal vasculitis. ATT, BCVA, TB
2011 Assessment of gelatinase and tumor necrosis factor-alpha level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease. MMP
2011 Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales' disease. ARMS-PCR
10  2011 Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease. hs-CRP, IL-6, SNP, VEGF
11  2011 Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease. TLR
12  2011 Total antioxidant capacity in Eales' disease, uveitis & cataract. TAC
13  2010 Serum interferon-gamma/interleukin-4 imbalance in patients with Eales' disease. IFN-gamma, NVH, TNF-alpha, VH
14  2009 Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED). ---
15  2009 Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease. IHC, MH, PDR
16  2008 Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. ELISA, IL-6, MCP-1, MH, PDR, PEDF, VEGF
17  2007 Eales' disease: oxidant stress and weak antioxidant defence. ---
18  2004 Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy. BRB, DTPA, ESR, MC, PMA, SOD, TBARS
19  2003 Accumulation of 8-hydroxydeoxyguanosine and its relationship with antioxidant parameters in patients with Eales' disease: implications for antioxidant therapy. AV, GC/MS, HV, SOD, TBARS
20  2003 Involvement of oxidative and nitrosative stress in promoting retinal vasculitis in patients with Eales' disease. ERM, iNOS, MC, MDA, RNS, ROS, RP-HPLC, SOD, TBARS
21  2003 Presence of a 88 kDa Eales protein in uveitis, tuberculosis, leprosy and rheumatoid arthritis. ERM, PAGE
22  1994 [Eales' disease involving central nervous system white matter]. MR